Emergent BioSolutions Inc. to Host Q2 2025 Financial Results Conference Call on August 6

Emergent BioSolutions will discuss Q2 2025 financial results on August 6, 2025, via conference call and webcast.

Quiver AI Summary

Emergent BioSolutions Inc. will hold a conference call on August 6, 2025, at 5:00 PM Eastern Time to discuss its financial results for the second quarter of 2025. Participants can join the call via a live webcast on Emergent’s Investors page or by registering in advance for a telephone option, which provides a unique passcode and ID for access. A replay of the call will be available on the same webpage. Emergent BioSolutions has been dedicated to protecting public health for over 25 years by providing solutions to various health threats, including those posed by diseases such as smallpox and Ebola. For more information about the company, visit their website and follow them on social media.

Potential Positives

The upcoming conference call provides an opportunity for the company to communicate its financial results and performance directly to investors, enhancing transparency.
Hosting the call via webcast allows broader access for stakeholders, promoting engagement and investor trust.
Emergent's long-standing mission to protect and save lives positions the company positively in the public health sector, reinforcing its commitment to important health threats.

Potential Negatives

The announcement of a conference call to discuss financial results could indicate potential concerns about the company's financial performance, raising questions among investors.
Requiring advance registration to participate in the call may limit accessibility for interested stakeholders, potentially leading to reduced engagement from investors and analysts.
Emergent's focus on past public health threats rather than upcoming innovations or future initiatives might suggest a lack of new developments, which could be seen as a weakness in their growth strategy.

FAQ

When is Emergent BioSolutions' second quarter 2025 earnings call?

The earnings call is scheduled for Wednesday, August 6, 2025, at 5:00 pm Eastern Time.

How can I access the conference call?

Participants can access the call live via webcast on Emergent’s Investors page or by telephone after registering in advance.

What should I do to participate by telephone?

To participate by telephone, register in advance to receive a confirmation email with dial-in details, passcode, and registrant ID.

Will there be a replay of the conference call?

Yes, a replay of the call will be available on the Investors page of Emergent's website after the event.

What is the mission of Emergent BioSolutions?

Emergent BioSolutions' mission is to protect and save lives by delivering solutions for public health threats.

Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.

$EBS Insider Trading Activity

$EBS insiders have traded $EBS stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $EBS stock by insiders over the last 6 months:

NEAL FRANKLIN FOWLER sold 35,000 shares for an estimated $204,050
KATHRYN C ZOON sold 10,000 shares for an estimated $57,300
KEITH KATKIN sold 7,844 shares for an estimated $49,417

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$EBS Hedge Fund Activity

We have seen 81 institutional investors add shares of $EBS stock to their portfolio, and 73 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

MILLENNIUM MANAGEMENT LLC added 1,020,582 shares (+68.9%) to their portfolio in Q1 2025, for an estimated $4,960,028
LSV ASSET MANAGEMENT added 809,591 shares (+3748.1%) to their portfolio in Q1 2025, for an estimated $3,934,612
INVESCO LTD. removed 791,948 shares (-51.4%) from their portfolio in Q1 2025, for an estimated $3,848,867
CHARLES SCHWAB INVESTMENT MANAGEMENT INC removed 706,959 shares (-54.8%) from their portfolio in Q1 2025, for an estimated $3,435,820
ACADIAN ASSET MANAGEMENT LLC added 631,794 shares (+313.5%) to their portfolio in Q1 2025, for an estimated $3,070,518
DIMENSIONAL FUND ADVISORS LP added 492,579 shares (+44.6%) to their portfolio in Q1 2025, for an estimated $2,393,933
TWO SIGMA INVESTMENTS, LP removed 449,966 shares (-53.1%) from their portfolio in Q1 2025, for an estimated $2,186,834

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$EBS Analyst Ratings

Wall Street analysts have issued reports on $EBS in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

HC Wainwright & Co. issued a "Buy" rating on 04/01/2025

To track analyst ratings and price targets for $EBS, check out Quiver Quantitative's $EBS forecast page.

Full Release

GAITHERSBURG, Md., July 15, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Wednesday, August 6, 2025, at 5:00 pm eastern time to discuss the financial results for the second quarter of 2025.

Participants can access the conference call live via webcast and also by visiting the Investors page of Emergent’s website. To participate via telephone, please register in advance at this link . Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call.

A replay of the call can be accessed from the Investors page of Emergent’s website.

About Emergent BioSolutions
At Emergent, our mission is to protect and save lives. For over 25 years, we’ve been at work preparing those entrusted with protecting public health. We deliver protective and life-saving solutions for health threats like smallpox, mpox, botulism, Ebola, anthrax and opioid overdose emergencies. To learn more about how we help prepare communities around the world for today’s health challenges and tomorrow’s threats, visit our website and follow us on LinkedIn , X , Instagram , Apple Podcasts and Spotify .

Investor Contact:
Richard S. Lindahl
Executive Vice President, CFO
[email protected]

Media Contact:
Assal Hellmer
Vice President, Communications
[email protected]